Expert opinion

Cashflow & Asset-Based Lending: Transforming Manufacturing & Industrials SMEs

Alexei Garan, Shaw & Co, looks at how cashflow and asset-based lending can provide an important boost for Manufacturing and Industrials companies with ambitions for growth…

5 minutes
March 25, 2025
Words:
Alexei Garan
Images:
PDF:
Report

We work with a range of companies in the Manufacturing and Industrials sectors and there remains a number of persistent challenges when it comes to growth, even for well-established and sizeable businesses.

For example, being largely capital-intensive sectors, raw materials, labour and overheads must be paid for long before customer invoices are settled – sometimes 60 or 90 days later. Invoice discounting helps by advancing funds against those invoices, typically up to 80-90% of their value. Yet, this retrospective approach only reflects work already completed. For businesses eyeing ambitious growth, it doesn’t address the upfront costs required to get there.

It is possible to borrow against raw materials or components stock, but advance rates are typically low and cover only a small portion of the overall growth funding required (whereas plant and machinery may already have hire purchase arrangements in place).

It is therefore unsurprising that we’re often hearing of plans being shelved or slower expansion being funded by owners dipping into personal reserves, remortgaging, or taking out other personal debt, a risky move but especially so in these uncertain times.

Asset-Based Lending (ABL)

To ensure growth, it is important that ABL facilities are carefully considered for capital intensive businesses. These can be funded across multiple asset classes mixed with an element of cashflow where there is a shortfall. The ultimate aim is to get a mix of facilities that provide enough headroom for growth plans and with all funding structures having been considered.

Cashflow Lending

Cashflow lending, meanwhile, is obviously based on a business’s projections – sales forecasts, order pipelines, growth plans and ultimately future earnings – to determine funding. This cashflow funding can be structured as part of a wider ABL facility from an ABL lender, or can sit behind an ABL facilities, providing an additional layer of capital, tailored to your future potential. Lenders assess your financials, market demand, and track record to offer a cashflow boost that aligns with your future ambition, not just your past.

For SMEs in manufacturing or industrials, this hybrid approach is a growth lifeline and can be a source of serious competitive advantage. Not only does it ensure that a business does not have to pass up new contracts or expansion opportunities, it is also assessed in line with deliverable earnings, therefore unlocking growth without diluting equity. Getting the facility limits right under and ABL facility is key in this regard and where multiple asset classes are being funded a detailed headroom model is essential.

Just like with any other obligations, such debt presents risks, which lenders control to some extent with covenants. To unlock potential whilst minimising risks, our work with clients starts with detailed interrogation of their cashflow forecasts, costing planned growth initiatives and stress testing key assumptions. Getting this right with a corporate finance advisor is vital and should be done before approaching the funding market, where different lenders have their own established ways of assessing any such funding propositions (lender confidence is all too easy to lose with lack of preparedness).

After sustaining the recent shocks of Covid, supply chain interruptions, the war in Ukraine, elections and other headwinds, many business owners are in no mood to postpone growth. ABL alongside cashflow lending is vital in ensuring that this growth finally takes place.

Alexei Garan is a Partner - Busing Funding at Shaw & Co

If you'd like to discuss how Shaw & Co can help you sell, buy or fund the growth of a business, please book a meeting here
Words:
Alexei Garan
 - 
Partner
Read 
Alexei Garan
's bio

CatSci, a highly innovative spin-out from AstraZeneca, approached Shaw & Co to source funding to support its long-term expansion plan...

Read case study

INDUSTRY Content

See all Shaw Reports
The Shaw Report: Leisure, Tourism & Sport - Interim Review #2

Shaw Report

|

June 27, 2023

The Shaw Report: Wholesale & Retail Trade - Annual Report #2

Shaw Report

|

June 27, 2023

The Shaw Report: Property & Construction - Annual Report #2

Shaw Report

|

May 30, 2023

The Shaw Report: Automotive, Transport & Logistics - Interim Review #2

Shaw Report

|

May 24, 2023

The Shaw Report: Manufacturing & Engineering - Interim Review #2

Shaw Report

|

May 10, 2023

The Shaw Report: Food & Drink - Interim Review #2

Shaw Report

|

May 9, 2023

The Shaw Report: Technology, Media & Telecoms - Interim Review #2

Shaw Report

|

April 17, 2023

The Shaw Report: Energy & Natural Resources - Annual Report #2

Shaw Report

|

March 28, 2023

The Shaw Report: Professional Services - Annual Report #2

Shaw Report

|

March 20, 2023

The Shaw Report: Banking, Financial & Insurance Services - Annual Report #2

Shaw Report

|

February 28, 2023

The Shaw Report - Healthcare & Life Sciences Annual Review December 2022

Shaw Report

|

December 14, 2022

The Shaw Report - Wholesale & Retail Trade Industry Interim Review December 2022

Shaw Report

|

December 14, 2022

The Shaw Report - Leisure, Tourism and Sport Annual Review November 2022

Shaw Report

|

November 29, 2022

The Shaw Report - Property & Construction Industry Interim Review November 2022

Shaw Report

|

November 23, 2022

The Shaw Report - Technology Media & Telecoms Industry Annual Review October 2022

Shaw Report

|

October 19, 2022

The Shaw Report - Automotive, Transport & Logistics Industry Annual Review October 2022

Shaw Report

|

October 12, 2022

The Shaw Report - Professional Services Industry Interim Review September 2022

Shaw Report

|

September 26, 2022

The Shaw Report - Manufacturing & Engineering Industry Annual Review September 2022

Shaw Report

|

September 1, 2022

The Shaw Report - Banking, Financial and Insurance Services Industry Interim Review August 2022

Shaw Report

|

August 23, 2022

The Shaw Report - Healthcare & Life Sciences Interim Review August 2022

Shaw Report

|

August 11, 2022

Food & Beverages Industry Report 2022

Shaw Report

|

July 22, 2022

The Shaw Report - Leisure, Tourism & Sport Interim Review July 2022

Shaw Report

|

July 19, 2022

The Shaw Report - Energy & Natural Resources Interim Review June 2022

Shaw Report

|

June 27, 2022

Shaw & Co launches annual analysis of wholesale & retail trade industry

Shaw Report

|

June 29, 2022

The Shaw Report - Automotive, Transport & Logistics Interim Review May 2022

Shaw Report

|

May 19, 2022

Shaw & Co Launches Annual Analysis of Property and Construction Industry

Shaw Report

|

May 6, 2022

The Shaw Report - TMT Interim Review May 2022

Shaw Report

|

May 5, 2022

The Shaw Report - Manufacturing & Engineering Interim Review April 2022

Shaw Report

|

April 8, 2022

The Shaw Report - Food & Drink Interim Review March 2022

Shaw Report

|

March 25, 2022

The Shaw Report - Professional Services Annual Review 2022

Shaw Report

|

March 17, 2022

The Shaw Report - Leisure, Tourism & Sport December 2021

Shaw Report

|

December 14, 2021

The Shaw Report - Health & Life Sciences December 2021

Shaw Report

|

December 10, 2021

The Shaw Report - Banking, Financial & Insurance Services December 2021

Shaw Report

|

December 8, 2021

The Shaw Report - Energy & Natural Resources November 2021

Shaw Report

|

November 16, 2021

The Shaw Report - Technology, Media & Telecoms October 2021

Shaw Report

|

October 28, 2021

The Shaw Report - Automotive, Transport & Logistics October 2021

Shaw Report

|

October 14, 2021

The Shaw Report - Manufacturing & Engineering October 2021

Shaw Report

|

October 1, 2021

The Shaw Report - Food & Drink September 2021

Shaw Report

|

September 27, 2021